Business Context and Reporting Period
Company: Petco Health & Wellness Company, Inc. (Ticker: WOOF)
Filing Type: Form 10-K (Annual Report)
Fiscal Year Ended: February 1, 2025 (52 weeks)
Business Overview: Petco is a pet specialty retailer operating an omnichannel ecosystem of products and services. As of February 1, 2025, the company operated 1,398 pet care centers in the U.S. and Puerto Rico, 142 centers in Mexico, and 2 in Chile. The company is indirectly controlled by CVC Capital Partners and Canada Pension Plan Investment Board (the "Sponsors"), who hold approximately 66% of the voting power.
Key Financial Metrics
| Metric | Fiscal 2024 (Ended Feb 1, 2025) | Fiscal 2023 (Ended Feb 3, 2024) |
|---|---|---|
| Total Net Sales | $6.12 billion | $6.26 billion |
| Comparable Sales Growth | 0.3% | 1.8% |
| Gross Profit | $2.32 billion (38.0% margin) | $2.35 billion (37.6% margin) |
| Operating Income (Loss) | $7.1 million | ($1.18 billion) |
| Net Loss Attributable to Stockholders | ($101.8 million) | ($1.28 billion) |
| Adjusted EBITDA | $336.5 million | $401.1 million |
| Free Cash Flow | $49.7 million | ($9.9 million) |
| Cash and Cash Equivalents | $165.8 million | $125.4 million |
| Total Debt Outstanding | $1.60 billion (Term Loan) | $1.60 billion (Term Loan) |
| ABL Revolving Credit Availability | $515.6 million | $500.0 million (prior to amendment) |
Material Changes Versus Prior Period
- Revenue Decline: Net sales decreased 2.2% to $6.12 billion. This decline was primarily driven by the absence of a 53rd week in fiscal 2024 (which existed in fiscal 2023) and a 6.2% decrease in supplies and companion animals sales due to softening discretionary spending. Conversely, services and other revenue grew 1.8%.
- Profitability Improvement: Operating income improved significantly from a loss of $1.18 billion in fiscal 2023 to a profit of $7.1 million in fiscal 2024. This turnaround was primarily due to the absence of a $1.22 billion goodwill impairment charge recorded in fiscal 2023.
- Adjusted EBITDA Decline: Adjusted EBITDA decreased 16.1% to $336.5 million, reflecting lower sales volume and ongoing investments in transformation initiatives.
- Cost Management: Selling, General, and Administrative (SG&A) expenses increased slightly to $2.32 billion (37.9% of sales) due to higher payroll and consulting fees related to transformation efforts, partially offset by lower stock compensation and advertising expenses.
Guidance, Outlook, and Risks
Management Commentary & Outlook: Management continues to focus on optimizing the assortment and store labor model to enhance profitability. The company is strategically investing in veterinary care, e-commerce, and services. Capital expenditures for fiscal 2025 are expected to be between $130 million and $140 million, a reduction from prior years driven by fewer new pet care center openings.
Key Risks and Contingencies:
- Consumer Spending: Persistent inflation and macroeconomic uncertainty have led to softening discretionary spending, particularly in supplies and companion animals.
- Competition: Intense competition from mass merchants, grocery retailers, and e-commerce providers continues to pressure pricing and margins.
- Debt Obligations: The company carries substantial indebtedness ($1.7 billion term loan facility), which restricts operating flexibility and requires significant cash flow for debt service. Interest rate risk remains a factor due to variable-rate debt, though the company utilizes caps, collars, and swaps to mitigate exposure.
- Goodwill Impairment: While no impairment was recorded in fiscal 2024, the company monitors goodwill and indefinite-lived intangible assets closely. A significant decline in stock price or market capitalization could trigger future impairment charges.
- Regulatory & Legal: Risks include compliance with veterinary practice laws, data privacy regulations (CCPA/CPRA), and potential product liability claims.
Investor Verification Checklist
- Debt Covenants: Verify compliance with financial maintenance covenants under the First Lien Term Loan and ABL Revolving Credit Facility, particularly the fixed charge coverage ratio.
- Goodwill Valuation: Review the assumptions used in the annual goodwill impairment test, specifically discount rates and terminal growth rates, given the company's history of impairment.
- Comparable Sales Quality: Analyze the composition of the 0.3% comparable sales growth to determine if it is driven by higher-margin services or lower-margin consumables.
- Liquidity Position: Confirm the borrowing base availability under the ABL facility, noting the $7.0 million reduction due to a shortfall in qualifying assets.
- Cost Reduction Initiatives: Monitor the execution of the store labor model optimization and assortment changes to ensure projected cost savings are realized.